Vitamin D is synthesized in skin through a reaction mediated by sunlight, and it is metabolized to
25-hydroxyvitamin D, in liver, and in
1,25-dihydroxyvitamin D, in kidney. This last reaction has a tight feedback mechanism.
1,25-dihydroxyvitamin D is the active
hormone, and its actions are mediated mainly by
nuclear receptors. Its major functions are in
calcium metabolism and bone mass maintenance. Hypovitaminosis D, as a disease in adult people, manifests itself with
hypocalcemia and
secondary hyperparathyroidism with subsequent loss of trabecular bone, thinning of cortical bone, and, eventually, a higher risk of fractures. Hypovitaminosis D is a very common condition in Europe, Africa, North America and some South American countries, such as Chile and Argentina. Measurement of serum total
25-hydroxyvitamin D concentration is the gold standard to diagnose
vitamin D deficiency. Serum concentrations below 50 nmol/L are associated with an increase in
parathyroid hormone concentration, and bone loss. Risk factors for
vitamin D deficiency, like poor sunlight exposition, aging skin and factors that interfere with normal
vitamin D metabolism, are well established. Oral
vitamin D supplementation, an easy and inexpensive treatment, is needed to treat this illness.